FDA Accuses Chewy, Pet Companies Of Selling Unapproved Antibiotics
(Washington, DC) -- The FDA is accusing Chewy and eight other pet product companies of selling unapproved animal antibiotics. The agency alleged on Thursday that the retailers violated federal law by selling unapproved medications containing penicillin and amoxicillin, which could help create drug-resistant "superbugs." A letter from the FDA says the products in question were targeted at birds and fish, and they're threatening legal action if the companies don't address the alleged violations within 15 days.